In vitro and in vivo treatment of MCC mouse models with a panel of PI3K inhibitors revealed markedly reduced tumor size and upregulated expression of caspase-3, indicating apoptosis activation in MCC cells when copanlisib was applied [33,79]. The gene discussed is CASP3; the disease is Merkel cell skin cancer.